SKLAR CORP
SC 13D/A, 1998-12-23
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: SKLAR CORP, SC 13D, 1998-12-23
Next: SKLAR CORP, SC 13D, 1998-12-23



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 1) *

                                SKLAR CORPORATION
                                (Name of Issuer)

      COMMON STOCK, $0.10 par value, Series A Convertible Preferred Stock,
                                 $0.10 par value
                         (Title of Class of Securities)

                                    584053300
                                 (CUSIP Number)

  Bari Krein, Esquire 2500 One Liberty Place, Philadelphia, Pennsylvania 19103
   (Name, Address and Telephone Number of Person Authorized to Receive Notices
                               and Communications)

                                November 30, 1998
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-l(b)(3) or (4), check the following box |_|.

Check the following box if a fee is being paid with the statement |_|. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-l(a) for other parties to whom copies are to be
sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>
                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 584053300                                         Page  1 of 5  Pages
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------
1         NAME OF REPORTING PERSON      Michael Malinowski
          S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

- --------------------------------------------------------------------------------
2         CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*             (a) |_|
                                                                        (b) |_|
- --------------------------------------------------------------------------------
3         SEC USE ONLY
- --------------------------------------------------------------------------------
4         SOURCE OF FUNDS*
                                       OO
- --------------------------------------------------------------------------------
5         CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO 
          ITEMS 2(D) OR 2(E) |_|
- --------------------------------------------------------------------------------
6         CITIZENSHIP OR PLACE OF ORIGINATION
                        United States of America
- --------------------------------------------------------------------------------


- --------------------------------------------------------------------------------
      NUMBER OF        7   SOLE VOTING POWER
       SHARES              260,024 shares of Common Stock   (See Item 5(a))
    BENEFICIALLY       ---------------------------------------------------------
      OWNED BY         8   SHARED VOTING POWER
       EACH                   None.
     REPORTING         ---------------------------------------------------------
      PERSON           9   SOLE DISPOSITIVE POWER
       WITH                260,024 shares of Common Stock   (See Item 5(a))
                       ---------------------------------------------------------
                       10  SHARED DISPOSITIVE POWER
                              None.
- --------------------------------------------------------------------------------
11      AGGREGATED AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        260,024 shares of Common Stock (See Item 5(a))
- --------------------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
                                                                            |_|
- --------------------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.8% of Common
        Stock (See Item 5(a))
- --------------------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*
                                       IN
- --------------------------------------------------------------------------------
<PAGE>
                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 584053300                                          Page  2 of 5 Pages
- --------------------------------------------------------------------------------

               Item 1.     Security and Issuer.

                  This Schedule 13D report relates to the Common Stock, par
               value $.10 per share of Sklar Corporation (the "Issuer"). The
               principal executive offices of the Issuer are located at 889
               South Matlack Street, West Chester, Pennsylvania, 19382.

               Item 2.     Identity and Background.

                  (a)  This statement is filed by Michael Malinowski.

                  (b)  His address is 613 Arberdeen Drive, Kennett Square, PA
                       19348.

                  (c)  Michael Malinowski was appointed a Director of the Issuer
               in April, 1991 and has served as Executive Vice President since
               1994 and Chief Financial Officer since 1998. He has been employed
               by the Issuer since 1986 in the positions of General Manager and
               Vice President of Operations. The Issuer is engaged in the
               business of importing and distributing surgical, dental and
               veterinary hand held precision stainless steel instruments. The
               principle business address of the Issuer is as set forth in Item
               1.

                  (d) Malinowski has not been convicted in a criminal proceeding
               (excluding traffic violations or similar misdemeanors) during the
               last five years.

                  (e) Malinowski has not been a party, during the last five
               years, to any civil proceeding or a judicial administrative body
               of competent jurisdiction which resulted his being subjected to a
               judgment, decree or final order enjoining future violations of,
               or prohibiting or mandating activities subject to, federal or
               state securities laws or finding any violation with respect to
               such laws.

                  (f) Malinowski is a citizen of the United States of America.

<PAGE>
                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 584053300                                         Page  3 of 5 Pages
- --------------------------------------------------------------------------------

               Item 3.     Source and Amount of Funds or Other Consideration.

                  The source of funds used by Malinowski in connection with the
               acquisition of securities of the Issuer described herein is
               personal funds. The amount of funds concerned in the acquisition
               of such securities as of the date of this report, aggregates
               approximately $20,000.

               Item 4.     Purpose of Transaction.

                  The Board of Directors of the Issuer is planning to propose a
               1-for-50,000 reverse stock split of the Company's Common Stock to
               the Issuer's Shareholders. In lieu of issuing any fractional
               shares, the Company will make a cash payment to Shareholders
               holding less than 50,000 shares of Common Stock. If effectuated,
               the transaction would result in the Common Stock being
               deregistered under Section 12(g) of the Securities and Exchange
               Act of 1934. Following the proposed reverse stock split, the
               Company believes that there will be approximately 11 outstanding
               shares of Common Stock of the Issuer.
                  On November 30, 1998, Malinowski exercised his option to
               purchase 100,000 shares of Common Stock which the Company granted
               him in May, 1993 under the Company's 1983 Incentive Stock Option
               Plan. (See Item 5(c)). His decision to exercise his options at
               that point was influenced by the upcoming Reverse Stock Split. On
               the same date, the Issuer granted Malinowski 100,000 shares of
               Common Stock as consideration for his personal guaranty of a line
               of credit for the Company. (See Item 5(c)). Malinowski intends to
               hold these additional shares for investment purposes.
                  Except as described in this Schedule 13D, including this Item
               4, neither Malinowski nor the Issuer have any plans or proposals
               which relate to or would result in; the acquisition by any person
               of additional securities of the Issuer, or the disposition of
               securities of the Issuer; an extraordinary corporate transaction,
               such as a merger, reorganization or liquidation, involving the
               Issuer or any of its subsidiaries; a sale or transfer of a
               material amount to assets of the Issuer or any of its
               subsidiaries; any change in the present board of directors or
               management of the Issuer, including any plans or proposals to
               change the number or term of directors or to fill any existing
               vacancies on the Board; any material change in the Issuer's
               business or corporate structure; causing the Issuer's securities
               to cease to be authorized to be quoted in an inter-dealer
               quotation system; or any action similar to any of those
               enumerated above.

<PAGE>

                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 584053300                                           Page 4 of 5 Pages
- --------------------------------------------------------------------------------

               Item 5.     Interest in Securities of the Issuer.

                  (a) Malinowski is presently the beneficial owner of 260,024
               shares of Common Stock of the Issuer; which represents
               approximately 23.8% of the Issuer's 1,093,423 shares of issued
               and outstanding Common Stock.
                  If the the proposed reverse stock split is effected, it is
               likely that Malinowski will be the beneficial owner of 5 shares
               of Common Stock, which will represent approximately 45.5% of the
               Issuer's 11 outstanding shares of Common Stock.

                  (b) Malinowski has the sole power to vote or to direct the
               vote of the 260,024 shares of Common Stock and will continue to
               have the sole power to vote or to direct the 5 shares of Common
               Stock following the effectiveness of the reverse stock split, if
               proposed as referred to in Item 5(a) above, and has the sole
               power to dispose or direct the disposition of such shares.

                  (c) On November 30, 1998, Malinowski exercised his option to
               purchase 100,000 shares of Common Stock at $0.20 per share. The
               Company granted him this option in May, 1993 under the Company's
               1983 Incentive Stock Option Plan.
                        On November 30, 1998, the Issuer granted Malinowski
               100,000 shares of Common Stock in consideration for his services
               in connection with his personal guaranty of a $2,000,000 line of
               credit with PNC Bank.

                  (d) No person other than Malinowski has the right to receive
               or the power to direct the receipt of dividends from, or the
               proceeds from the sale of the securities referred to in this
               Schedule 13D as being owned by him.

                  (e)   Not Applicable.

               Item 6.   Contract, Arrangements, Understanding or Relations
                         with Respect to the Securities of the Issuer

                  None.

<PAGE>

                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO. 584053300                                         Page  5 of 5 Pages
- --------------------------------------------------------------------------------

               Item 7.     Materials to be Filed as Exhibits
                  None.



<PAGE>

                                    SIGNATURE

                  After reasonable inquiry and to the best of my knowledge and
               belief, the undersigned certifies that the information set forth
               in the Statement is true, correct and complete.

               DATED:      December 21, 1998.


                                              /s/ Michael Malinowski
                                              ----------------------



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission